Grants for Small businesses - Income Security and Social Services

This grant provides financial support for independent research projects led by clinicians and scientists to improve medical knowledge and patient care, particularly for unmet medical needs.

This funding opportunity provides financial support to small community organizations and Tribal entities in New England to tackle environmental and public health issues in disadvantaged communities.

This funding opportunity supports researchers and institutions in developing innovative, non-addictive pain treatments through early-stage drug discovery and assay development, with a focus on alternatives to opioid therapies.

The Orange County Business Investment Grant Program in North Carolina is seeking applications to provide financial support ranging from $1,000 to $10,000 to stimulate non-farm business development and expansion within the county, with eligibility criteria including the business's physical location, operational duration, tax status, and connection with business counseling services.

This program provides financial support to non-farm businesses in Orange County, particularly those owned by women and BIPOC, to help them grow, hire staff, and make a positive economic impact.

This funding opportunity provides financial support to state and local governments, educational institutions, and nonprofit organizations to collaborate on improving child welfare practices through innovative data use and research partnerships.

This grant opportunity allows Skilled Nursing Facilities to apply for funding to purchase tablets and tablet-related accessories. Facilities must attest the tablets will be used for facilitating virtual telehealth or family visits for residents. Facilities must be certified through the Centers of Medicare and Medicaid Services (CMS). Applicants may generally request up to $3,000.00, however requests beyond $3,000.00 will be accepted and will require CDPH and CMS review. Applicants must use the template provided on the CDPH website; cover letters are not required. Keywords: Tablet, Communicative Technology, Skilled Nursing Facility, CMS, CDPH, CMP, Civil Money Penalty, Public Health, SNF

This funding opportunity provides financial support to organizations in Illinois to establish a peer-staffed phone line that offers free, confidential emotional support and resources for individuals facing mental health challenges.

This funding opportunity provides financial support to pediatric and family medical practices in New York State to implement the HealthySteps model, which enhances early childhood development and mental health services for children ages 0–3 and their families, particularly in underserved areas.

This funding opportunity supports projects that promote sustainable pest management practices to protect human health and the environment, particularly in underserved communities and agricultural areas near schools.

The COVID-19 PA Hazard Pay Grant Program was established to help employers provide hazard pay to employees in life-sustaining occupations during the coronavirus (COVID-19) pandemic. Hazard pay is intended to keep front-line employees working in sectors that are vital to every Pennsylvanians’ existence. The program will help employers provide hazard pay for their employees to retain current employees. This reimbursement-based grant is for employers who will be offering hazard pay over the eligible program period. For general questions about the program or specific application questions, visit our Hazard Pay FAQs. Hazard Pay FAQs Financial Info: The COVID-19 PA Hazard Pay Grant Program was established to help employers provide hazard pay to employees in life-sustaining occupations during the coronavirus (COVID-19) pandemic. Hazard pay is intended to keep front-line employees working in sectors that are vital to every Pennsylvanians’ existence. The program will help employers provide hazard pay for their employees to retain current employees. This reimbursement-based grant is for employers who will be offering hazard pay over the eligible program period. For general questions about the program or specific application questions, visit our Hazard Pay FAQs. Hazard Pay FAQs

This funding opportunity supports research projects that investigate individual differences in pain experiences and treatment responses, aiming to develop personalized pain management strategies while addressing the opioid crisis.

This funding opportunity supports U.S.-based organizations in evaluating the impact of upcoming public policies and programs that aim to improve health behaviors and reduce chronic disease risk factors through behavioral changes.

This funding opportunity supports U.S.-based researchers and organizations in developing non-addictive pain relief therapies to combat the opioid crisis, with a focus on advancing preclinical candidates toward clinical trials.

This grant provides funding to cultural organizations in New York City to create promotional materials and events that attract tourists to local cultural institutions and activities.

This funding opportunity provides financial support for researchers to analyze existing data on late talking children, particularly focusing on underrepresented populations, to better understand their developmental trajectories and improve language outcomes.

This funding opportunity supports U.S.-based small businesses in developing innovative, non-addictive therapies and technologies for improved pain management, addressing the opioid crisis through preclinical research and technological advancements.

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

This funding opportunity provides $15 million to organizations that will develop training and support resources for Head Start programs, focusing on improving early learning, health, and family engagement for children and families.

Funding available through this RFA supports the ongoing research and development of diagnostic tests and devices to treat, detect, diagnose, monitor, and assist in the treatment of cancer. Relevant areas include: Devices and assays for cancer detection, diagnosis, prognosis, monitoring, treatment and prediction of response or resistance to treatment Markers for cancer prevention and control, companion diagnostic to a therapy Development of diagnostic tests to distinguish high-risk early lesions Generally, at the time that an applicant applies to CPRIT pursuant to this RFA, the company has developed a commercial prototype of the device or a pictorial representation of the functional components/elements of the device. With respect to diagnostics, the company has developed assays that work on human samples and whose importance is well justified for development into clinical assays. The applicant should be working toward submitting an Investigational Device Exemption (IDE) or a 510(k) or Premarketing Approval (PMA) and is typically within one year from filing an IDE (or later stage work.) Potential applicants that are not at or near this stage of product development should consider applying for a Texas Seed Company Award. With appropriate justification, companies may use CPRIT funds to support studies that establish preclinical proof of concept, product validation, design, production, manufacturing and development, and clinical studies demonstrating safety and efficacy.